Discovery channel feed – Endpoints News

Discovery channel feed

Two Church lab vets, a secretive institute and an Israeli billionaire hunt for drugs in the guts of wild animals

5 years ago

Is a 'super-seasonal' flu vaccine on the horizon? The NIH and UW are taking a shot into the clinic this April

5 years ago

Montreal AI startup with a touted advisor licenses its 'few-shot' platform to Repare for synthetic lethality molecules

5 years ago

Can a CRISPR startup succeed where Pfizer, GlaxoSmithKline, Biogen and Genentech failed and cure chronic pain?

5 years ago

Lilly disses Amgen and Mirati as it debuts new KRAS molecule

5 years ago

In race for in vivo sickle cell cure, Intellia unveils (very) early proof-of-concept

5 years ago

David Liu has a new big idea: proteome editing. It could one day shred tau, RAS and some of the worst disease-causing proteins

5 years ago

Scoop: Deerfield and Dana-Farber forge closer ties to launch a new translational cancer research engine

5 years ago

Can a new CRISPR technique unlock the secrets of how cancer spreads?

5 years ago

Oxford gets £100M to seize a 'breakthrough moment' in fighting superbugs

5 years ago

Eli Lilly tees up discovery pact worth more than $1.6B with Merus for T cell-focused bispecific antibodies

5 years ago

As coronavirus variants trigger new alarms, the NIH is putting an under-the-radar ‘next-gen’ vaccine into PhI

5 years ago

Looking to leapfrog antibodies and RNAi, Sekar Kathiresan says gene editing approach to cut PCSK9 looks durable

5 years ago

GlaxoSmithKline makes big down payment on biotech targeting 'synthetic viability' with startup funding, pipeline deals

5 years ago

They thought their gene therapy failed. Instead, it spawned a medical mystery

5 years ago

Looking to solve public health crises through discovery, Gates Foundation taps AI firm Exscientia to look for answers

5 years ago

Penn researchers find a way through the labyrinth keeping CAR-T from solid tumors

5 years ago

Parker Institute summoned the neoantigen pioneers to compare their prediction algorithms. And they have some suggestions for the field

5 years ago

Three scientists win Nobel Prize in Medicine for work in discovering hepatitis C virus

5 years ago

Immetas Therapeutics nabs $11M Series A to narrow their bispecific work targeting inflammation in age-related diseases

5 years ago

Scripps reaches $10M settlement with government over allegations NIH grants weren't properly accounted for

5 years ago

An old Vertex drug gets new life as an Alzheimer's treatment, but human studies still far off

5 years ago

Researchers at City of Hope combine oncolytic virus with a CAR-T to eradicate solid tumors in mice

5 years ago

Researchers teamed up to develop a 'three in one' HIV treatment — and the NIH is throwing in $14.6M

5 years ago

First page Previous page 2 3 456 7 8 Next page Last page